Actively Recruiting
Transdiagnostic Internet Cognitive-behavior Therapy for Mixed Anxiety and Depressive Symptoms in Postnatal Women
Led by Université de Sherbrooke · Updated on 2025-05-13
226
Participants Needed
4
Research Sites
60 weeks
Total Duration
On this page
Sponsors
U
Université de Sherbrooke
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research project aims to examine the acceptability and efficacy of a French-Canadian adaptation of a postnatal anxiety and depression program. The main question it aims to answer is: \[1\] When the adapted postnatal Internet-delivered cognitive behavioral therapy (iCBT) is added to treatment as usual (TAU) in community-based care for women with anxiety and depressive symptoms, is the iCBT+TAU condition more effective to reduce symptoms than TAU alone? Participants will: postnatal iCBT group -\> Answer questionnaires before, after (week 6) and 4 weeks after the intervention (week 10); do the 6-week non-guided iCBT program for anxiety and depressive symptoms during the postnatal period. Waitlist, TAU group -\> Answer questionnaires at enrolment, at week 6 and week 10. Participants will have access to the intervention after they complete their last questionnaires.
CONDITIONS
Official Title
Transdiagnostic Internet Cognitive-behavior Therapy for Mixed Anxiety and Depressive Symptoms in Postnatal Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years and older
- Within 12 months postpartum
- Fluent in spoken and written French
- Self-reported clinical score 210 for anxiety and/or depressive symptoms based on the Generalised Anxiety Disorder-7 (GAD-7) and the Edinburgh Postnatal Depression Scale 10-item scale (EPDS)
- Access to a computer/tablet and internet connection
- Agreement to share primary provider contact information
You will not qualify if you...
- Self-reported diagnosis of schizophrenia or bipolar disorder
- Current substance abuse or dependence
- Current use of benzodiazepines
- Beginning psychological therapy (< 4 weeks ago) or medication (< 8 weeks ago) for depression/anxiety
- Severe depression (EPDS score 23) or active suicidal intentions (EPDS question 10 = 3, yes quite often)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Centre intégré de santé et services sociaux de la Montérégie-Ouest
Châteauguay, Quebec, Canada
Actively Recruiting
2
Centre intégré de santé et services sociaux de la Montérégie-Est
Greenfield Park, Quebec, Canada
Actively Recruiting
3
Centre intégré de santé et services sociaux de la Montérégie-Centre
Longueuil, Quebec, Canada, J4V 2H2
Actively Recruiting
4
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, J1H5H3
Actively Recruiting
Research Team
P
Pasquale Roberge, PhD
CONTACT
A
Alexandra Chapdelaine, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here